维普中文期刊产品整合服务
10篇 您的检索式:作者名="Ivgi"
    题名 作者 年代 出处 被引量
1Thalidomide reduces serum creactive protein and interlankin-6 and induces response to IL-2 in afraction of metastatic renal cell cancer patients who failed IL-2-based therapy显示文摘Kedar I Mermershtain W Ivgi H 2004Int J Cancer2004,110,2:1
2Neutrophil gelatinase-associ-ated lipocalin as a predictor of complications and mortality in pa- tients undergoing non-cardiac major surgery 显示文摘Shavit L Dolgoker I Ivgi H 2011Kidney Blood Press Res2011,34,:1
3Neutrophil gelatinase- associated lipoealin as a predictor of complications and mortality in patients undergoing non-cardiac major surgery 显示文摘Shavit L Dolgoker I Ivgi H Kidney Blood Press Res0,34,2:1
4Neutrophil gelatinase-associated lipocalin as a predictor of complications and mortality in patients undergoing non-cardiac major surgery显示文摘Shavit L Dolgoker I Ivgi H 2011Kidney Blood Press Res2011,34,2:1
5Neutrophil gelatinase - associated lipoealin as a predictor of complications and mortality in patients undergoing non - cardiac major surgery 显示文摘Shavit L Dolgoker I Ivgi H 2011Kidney Blood Press Res2011,34,2:1
6Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy显示文摘Kedar I Mermershtain W Ivgi H 2004Int J Cancer2004,110,2:1
7Neutrophil gelatinase-associ-ated lipocalin as a predictor of complications and mortality in patients undergoing non-cardiac major surgery显示文摘Shavit L D I Ivgi H A M Slotki I 0,,02:1
8Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy 显示文摘Kedar I Mermershtain W Ivgi H 2004Int J Cancer2004,110,2:1
9Suvorexant in pa- tients with insomnia: Results from two 3 - month randomized con- trolled clinical trials显示文摘Herring WJ Connor KM Ivgy - May N 2014Biol Psychiatry2014,00,:1
10Thalidomide reduces serum C- reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2- based therapy显示文摘Kedar I Mermershtaiu W Ivgi H 2004Int J Cancer2004,110,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费